Претраживање
Приказ резултата 1-3 од 3
Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits in an experimental Alzheimer's disease in rats
(Taylor & Francis Ltd, Abingdon, 1997)
It is well known that disturbance of calcium homeostasis has a significant role in the development of neurodegenerative disorders, such as Alzheimer's disease (AD). Our recent data suggest that acute treatment with the ...
Effect of physostigmine and verapamil on active avoidance in an experimental model of Alzheimer's disease
(Taylor & Francis Ltd, Abingdon, 1997)
The present study was performed to investigate and compare the effect of acetylcholinesterase inhibitor, physostigmine (0.045, 0.060 and 0.075 mg/kg sc, 30 min before the tests) and Ca-antagonist, verapamil (1.0, 2.5, 5.0 ...
Open field behavior in nucleus basalis magnocellularis-lesioned rats treated with physostigmine and verapamil
(Taylor & Francis Ltd, Abingdon, 1997)
The present study was done to investigate and compare the effect of acetylcholinesterase inhibitor, physostigmine (0.030, 0.045, 0.060 and 0.075 mg/kg sc) and Ca-antagonist, verapamil (1.0, 2.5, 5.0 and 10.0 mg/kg sc) on ...